PTEN is known to increase the number of G1-phase cells and, concomitantly, it reduces the number of S-phase cells, a key stage of DNA synthesis; these actions inhibit the uncontrolled proliferation of cancer cells. The gene discussed is PTEN; the disease is cancer.